Benefits of PCI–Capable Facility Openings Vary by Race, Community
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 15, 2023 -- There are differential benefits associated with a percutaneous coronary intervention–capable facility (PCI-CF) opening based on patient race and community segregation, according to a research letter published online Dec. 12 in JAMA Network Open.
Renee Y. Hsia, M.D., from University of California, San Francisco, and Yu-Chu Shen, Ph.D., from the Naval Postgraduate School in Monterey, California, examined differential changes in patient outcomes after PCI-CF openings by patient race and community segregation. Analysis included 2.39 million patients with Medicare Fee-for-Service and acute myocardial infarction (AMI; 2006 through 2017).
The researchers found that patients in integrated communities had larger increases in their probability of PCI during a hospitalization (Black patients: 6.62 percentage points and White patients: 5.28 percentage points) versus those in segregated communities (3.60 percentage points and 2.20 percentage points for Black and White patients, respectively) after a PCI-CF opening. These changes yield a 12.3 percent relative increase for Black patients in integrated communities and a 3.5 percent relative increase for White patients in segregated communities. For 30-day mortality, Black patients in integrated communities had a 1.30 percentage point decrease (roughly 10.7 percent relative decrease), which persisted at one year (1.86 percentage point decrease, or 6.2 percent relative decrease) after a PCI-CF opening.
"Our findings reveal potential avenues for improving PCI resource allocation, including the implementation of public health measures or financial incentives to support PCI-CF openings in majority Black and integrated communities and greater structural reform targeting the built environment of health care services," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-16 02:15
Read more
- 1.5 Million U.S. Adults Have Vision-Affecting Glaucoma
- Ozempic, Wegovy Could Help Ease Knee Arthritis Pain
- Autism Diagnoses Rising Among U.S. Children, Adults
- Kidney Transplant Noninferior From Donors With Versus Without HIV in HIV-Positive Recipients
- Too Much Sitting Harms the Heart, Even in Folks Who Exercise
- Smoking Tied to Increased Opioid Use
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions